tirzepatide winter garden cuts risk of diabetes by 94% in adults with prediabetes and obesity or overweight, drugmaker says Tirzepatide Weight Loss in Chicago

Primary research: Obesity, type 2 diabetes, metabolic syndrome Mechanism: Simultaneous activation of GLP-1 (appetite suppression), GIP (insulin sensitization), and glucagon (fat oxidation) receptors Regulatory status: Investigational

Remember to rotate your injection sites among the abdomen, thigh, or upper arm to minimize discomfort

This mechanism helps reduce the risk of hypoglycemia compared to some other diabetes medications, though the risk increases when used with insulin or sulfonylureas

Wegovy and Ozempic contain semaglutide, a GLP-1 receptor agonist that slows the emptying of the stomach

This is a moderate injection volume that most people tolerate well